Century Therapeutics, INC. (IPSC) — 10-Q Filings

10-Q Filings (6)

• Century Therapeutics Swings to 9-Month Profit on Collaboration Windfall — Nov 13, 2025 Risk: high
  Century Therapeutics, Inc. (IPSC) reported a net income of $9,591,000 for the nine months ended September 30, 2025, a significant improvement from a net loss of
• Century Therapeutics Swings to Profit on Bristol-Myers Squibb Deal Termination — Aug 14, 2025 Risk: high
  Century Therapeutics, Inc. (IPSC) reported a net income of $44.019 million for the six months ended June 30, 2025, a significant turnaround from a net loss of $
• Century Therapeutics Files Q1 2025 10-Q — May 15, 2025 Risk: low
  Century Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information including retained earnings, additional
• Century Therapeutics Files Q3 2024 10-Q — Nov 5, 2024 Risk: medium
  Century Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial position, including assets and li
• Century Therapeutics Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Century Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and operational updates. Key financial fig
• Century Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  Century Therapeutics, Inc. (IPSC) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Century Therapeutics, Inc. filed a 10-Q report on May 9, 2024, fo

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX